High-dose-rate intraluminal brachytherapy during preoperative chemoradiation for locally advanced rectal cancers

doi:10.3748/wjg.v16.i35.4436

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 35

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6448)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

431

HTML

5546

Figures (1-3)

230

Tables (1-4)

241

Sum=6448

Sep 21, 2010 (publication date) through Feb 1, 2025

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 21, 2010; 16(35): 4436-4442
Published online Sep 21, 2010. doi: 10.3748/wjg.v16.i35.4436

Table 3 Pathologic response in both groups n (%)

Pathologic stage	Group A (HDR-ILBT) (n = 17)	Group B (control arm) (n = 19)	P value
yp T stage
ypT0	10 (58.8)	3 (15.8)	0.0001
ypT1	3 (17.6)	6 (31.6)
ypT2	1 (5.9)	4 (21)
ypT3	2 (11.8)	5 (26.3)
ypT4	1 (5.9)	1 (5.3)
yp N stage
ypN0	6 (60)	5 (50)	0.02
ypN+	4 (30)	5 (50)

Group A: High dose rate intraluminal brachytherapy boost; Group B: External beam radiation therapy boost. HDR-ILBT: High dose rate intraluminal brachytherapy.

Citation: Tunio MA, Rafi M, Hashmi A, Mohsin R, Qayyum A, Hasan M, Sattar A, Mubarak M. High-dose-rate intraluminal brachytherapy during preoperative chemoradiation for locally advanced rectal cancers. World J Gastroenterol 2010; 16(35): 4436-4442
URL: https://www.wjgnet.com/1007-9327/full/v16/i35/4436.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i35.4436